T32 Training Program in Mechanisms and Innovation in Vascular Disease

项目摘要 这项T32转化性血管研究培训计划建立在斯坦福大学 心血管研究所，提供宝贵的独特和创新的职业发展机会 给一群在血管疾病管理方面有前途的早期职业研究人员。它支持NHLBI 使命是开发预防、诊断和治疗心血管疾病的新的综合战略，同时在 同时实现其教育目标，培训未来的领导者基础、翻译和应用血管 研究。这款T32是斯坦福大学唯一在全校范围内开发下一代翻译的努力 血管调查员。该计划的目标包括严格的科学方法培训，批判性分析， 在高度协作的多学科环境中进行逻辑推理和独立思考。实习生发展 血管研究专长的重点领域，并接触到广泛的互补性研究 技巧。导师提供口头和书面指导，是大学合作和高效协作的典范 沟通和灌输对负责任的研究行为的尊重。我们过去的实习生继续 成为一流学术机构和行业的独立研究人员，并成为 血管研究领域。 该计划建议继续培训6名多学科血管研究的博士后研究员。研究员 每年都被任命到这个T32，强烈鼓励他们寻求自己的资金再多几年 作为该计划传授的技能的一部分。到目前为止，已有31名学员从该计划中受益，其中包括18名学员 妇女和4个代表不足的少数族裔。目前有六人正在接受培训。评估表明， 对计划的满意度。该项目由医学教授曹菲利普博士(联系人Pi)指导， 斯坦福大学医学院；弗吉尼亚州帕洛阿尔托卫生保健精准医学副参谋长 斯坦福大学血管内科主任、外科和内科教授Nicholas Leeper博士说。 行政和项目管理支持由斯坦福大学的一支专门的教育团队提供 心血管研究所。由来自广泛领域的斯坦福大学高级教职员工组成的内部咨询委员会 学科和由血管医学和研究领域的领先专家组成的外部咨询委员会 美国在监督这一培训计划的进展方面发挥着至关重要的作用，提供持续的支持和建议 视需要而定。我们的首要目标是培训下一代血管研究人员，以及 以促进他们转变为多产和成功的学术和行业领导者。

Project Summary This T32 translational vascular research training program builds on the capabilities of the Stanford Cardiovascular Institute, which provides valuable unique and innovative professional development opportunities to a diverse group of promising early career investigators in vascular disease management. It supports NHLBI’s mission to develop novel integrative strategies to prevent, diagnose, and treat cardiovascular diseases, while at the same time fulfilling its educational goal to train tomorrow’s leaders in basic, translational, and applied vascular research. This T32 is Stanford's only University-wide effort to develop the next generation of translational vascular investigators. The program goals include rigorous training in the scientific method, critical analysis, logical reasoning and independent thinking in a highly collaborative, multidisciplinary setting. Trainees develop a focused area of vascular research expertise and are exposed to a wide range of complementary research techniques. Mentors model collegial and productive collaboration provide guidance in oral and written communication and instill respect for the responsible conduct of research. Our past trainees have gone on to become independent researchers in premier academic institutions and in industry and are emerging leaders in the field of vascular research. The program proposes to continue training 6 postdoctoral fellows in multidisciplinary vascular research. Fellows are appointed to this T32 annually, with a strong encouragement to seek their own funding for additional years as part of the skills imparted by the program. 31 trainees so far have benefited from this program, including 18 women and 4 underrepresented minorities. Six are currently in training. Evaluations suggest a high degree of satisfaction with the program. The Program is directed by Philip Tsao, PhD (Contact PI), Professor of Medicine, Stanford University School of Medicine; Associate Chief of Staff -Precision Medicine, VA Palo Alto Health Care System, and Nicholas Leeper, MD, Professor of Surgery and Medicine; Chief, Vascular Medicine, Stanford. Administrative and program management support is provided by a dedicated team of educators in the Stanford Cardiovascular Institute. An Internal Advisory Board consisting of senior Stanford faculty from a broad range of disciplines and an External Advisory Board consisting of leading experts in vascular medicine and research in the US play a vital role in monitoring the progress of this training program, providing ongoing support and advice as needed. Our overarching goal is to train the next generation of investigators in vascular research, and to facilitate their transition into productive and successful academic and industry leaders.